BURLINGTON, Mass., July 11, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Seventh Annual JMP Securities Healthcare Conference at the Peninsula New York Hotel in New York, NY. David B. Roberts, President, will provide an update on the company on Thursday, July 12, 2012 at 9:30 a.m. EDT.
LeMaitre Vascular, Inc. will also be hosting an Analyst Day to update the investment community on the Company, its growth initiatives and strategic priorities. Analyst Day will be held Wednesday, September 26, 2012 at Ruth's Chris Steakhouse, 148 W 51st Street, New York, NY and will begin at 9:30 am EDT and conclude at 12:30pm EDT. Please contact Brian Kickham (ir@lemaitre.com) for more information regarding Analyst Day.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the Over-the-Wire LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt and The UnBalloon.
The LeMaitre Vascular, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10015
Our principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.